T. Rowe Price Health Sciences Fund I Class (THISX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
76.74
-0.90 (-1.16%)
Jul 18, 2025, 4:00 PM EDT
-22.21%
Fund Assets11.05B
Expense Ratio0.67%
Min. Investment$500,000
Turnover52.40%
Dividend (ttm)10.40
Dividend Yield13.40%
Dividend Growth127.21%
Payout FrequencyAnnual
Ex-Dividend Daten/a
Previous Close77.64
YTD Return-3.73%
1-Year Return-2.46%
5-Year Return29.68%
52-Week Low72.14
52-Week High102.82
Beta (5Y)0.62
Holdings236
Inception DateMar 24, 2016

About THISX

The investment seeks long-term capital appreciation. The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies.

Fund Family T. Rowe Price
Category Health
Stock Exchange NASDAQ
Ticker Symbol THISX
Share Class T. Rowe Price Health Sciences Fund-i Class
Index S&P 500 TR

Performance

THISX had a total return of -2.46% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.73%.

Top 10 Holdings

46.67% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY10.72%
UnitedHealth Group IncorporatedUNH7.11%
Intuitive Surgical, Inc.ISRG4.92%
Stryker CorporationSYK4.45%
Thermo Fisher Scientific Inc.TMO3.94%
ARGENX SEn/a3.54%
Vertex Pharmaceuticals IncorporatedVRTX3.27%
Boston Scientific CorporationBSX3.14%
Danaher CorporationDHR3.07%
Alnylam Pharmaceuticals, Inc.ALNY2.51%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 16, 2024$10.4019Dec 17, 2024
Dec 15, 2023$4.578Dec 18, 2023
Dec 15, 2022$1.5867Dec 16, 2022
Dec 15, 2020$1.020Dec 16, 2020
Dec 16, 2019$5.120Dec 17, 2019
Dec 14, 2018$4.490Dec 17, 2018
Full Dividend History